Ibrutinib and rituximab induced rapid response in refractory Richter syndrome

We report a 53-year-old man diagnosed with Richter syndrome. He was heavily pretreated and was refractory to prior therapy. He received rituximab and ibrutinib, and achieved a significant response after 1 month of therapy. Our case illustrates the importance of investigation of rituximab and ibrutin...

Full description

Saved in:
Bibliographic Details
Published in:Clin Case Rep
Main Authors: Lamar, Zanetta, Kennedy, LeAnne, Kennedy, Brooke, Lynch, Mary, Goad, Amanda, Hurd, David, McIver, Zachariah
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2015
Subjects:
Case Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527807/
https://ncbi.nlm.nih.gov/pubmed/26273453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.269
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items